Sawai Group Holdings
4887.TTSE PRIMEPharmaceutical
In English · 4
Fri, Nov 6 · JST1 filing
14:465% STAKESawai Group Holdings · Silchester International Investors LLP · 6.85% → 7.91%+1.06ppMon, Sep 28 · JST1 filing
11:135% STAKESawai Group Holdings · Silchester International Investors LLP · 5.82% → 6.85%+1.03ppTue, May 27 · JST1 filing
09:50MATERIALSawai Group Holdings · Event with a material impact on financial positionFri, Jul 19 · JST1 filing
11:51MATERIALSawai Group Holdings · Event with a material impact on financial positionAll EDINET filings · 93
| Filed | Document | Source |
|---|---|---|
| 2026-07-24 | Shelf registration supplementRelated to S100XG8F | S100YS6F |
| 2026-07-22 | Amended shelf registrationRelated to S100XG8F | S100YRMJ |
| 2026-06-30 | Amended shelf registrationRelated to S100XG8F | S100YNAX |
| 2026-06-24 | Internal control report | S100YIU4 |
| 2026-06-24 | CEO/CFO certification | S100YIU3 |
| 2026-01-29 | Shelf registration | S100XG8F |
| 2025-11-14 | CEO/CFO certification | S100X3BD |
| 2025-06-24 | CEO/CFO certification | S100W39L |
| 2025-06-24 | Internal control report | S100W39O |
| 2024-11-11 | CEO/CFO certification | S100UPEO |
| 2024-06-25 | Internal control report | S100TS2Y |
| 2024-06-25 | CEO/CFO certification | S100TS2U |
| 2024-02-14 | CEO/CFO certification | S100SW2Z |
| 2023-11-10 | CEO/CFO certification | S100S5XA |
| 2023-06-27 | CEO/CFO certification | S100R1HC |
| 2023-06-27 | Internal control report | S100R1G3 |
| 2022-06-24 | Internal control report | S100OEN1 |
| 2022-06-24 | CEO/CFO certification | S100OEKX |
EDINET catalog 2017-01-01 → 2026-10-03; earlier dates still being collected. 3 financial reports not structured yet.